To evaluate the clinical effectiveness of neuromodulation therapies that explicitly target pathological synchronous activity to reduce tinnitus perception in order to reduce tinnitus distress.

To evaluate the effectiveness of neuromodulation therapies in terms of reduced co-morbid symptoms and improved quality of life.

To review the physiological changes and adverse events associated with different neuromodulation (desynchronisation) therapies.